| Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials E Giannetta, T Feola, D Gianfrilli, R Pofi, V Dall’Armi, R Badagliacca, ... BMC medicine 12, 1-18, 2014 | 96 | 2014 |
| Pegvisomant improves glucose metabolism in acromegaly: a meta-analysis of prospective interventional studies T Feola, A Cozzolino, I Simonelli, E Sbardella, C Pozza, E Giannetta, ... The Journal of Clinical Endocrinology & Metabolism 104 (7), 2892-2902, 2019 | 77 | 2019 |
| Somatostatin analogs and glucose metabolism in acromegaly: a meta-analysis of prospective interventional studies A Cozzolino, T Feola, I Simonelli, G Puliani, C Pozza, E Giannetta, ... The Journal of Clinical Endocrinology & Metabolism 103 (6), 2089-2099, 2018 | 67 | 2018 |
| Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study T Feola, G Puliani, F Sesti, R Modica, R Centello, R Minotta, G Cannavale, ... Journal of Endocrinological Investigation 45 (4), 849-857, 2022 | 47 | 2022 |
| Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective G Muscogiuri, B Altieri, M Albertelli, A Dotto, R Modica, L Barrea, ... Endocrine 69, 441-450, 2020 | 46 | 2020 |
| Sex-specific effects of daily tadalafil on diabetic heart kinetics in RECOGITO, a randomized, double-blind, placebo-controlled trial R Pofi, E Giannetta, T Feola, N Galea, F Barbagallo, F Campolo, ... Science Translational Medicine 14 (649), eabl8503, 2022 | 37 | 2022 |
| NETest: a systematic review focusing on the prognostic and predictive role G Puliani, V Di Vito, T Feola, F Sesti, R Centello, C Pandozzi, ... Neuroendocrinology 112 (6), 523-536, 2022 | 36 | 2022 |
| ENDOCRINE TUMOURS: Calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus E Giannetta, V Guarnotta, B Altieri, C Sciammarella, E Guadagno, ... European Journal of Endocrinology 183 (6), R197-R215, 2020 | 36 | 2020 |
| Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies RM Ruggeri, E Benevento, F De Cicco, B Fazzalari, E Guadagno, ... Journal of Endocrinological Investigation 46 (2), 213-234, 2023 | 33 | 2023 |
| Emerging therapies in pheochromocytoma and paraganglioma: immune checkpoint inhibitors in the starting blocks G Fanciulli, S Di Molfetta, A Dotto, T Florio, T Feola, M Rubino, F de Cicco, ... Journal of Clinical Medicine 10 (1), 88, 2020 | 33 | 2020 |
| Pancreatic neuroendocrine neoplasms: does sex matter? G Muscogiuri, L Barrea, T Feola, M Gallo, E Messina, MA Venneri, ... Trends in Endocrinology & Metabolism 31 (9), 631-641, 2020 | 31 | 2020 |
| From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? G Vitale, A Dicitore, L Barrea, E Sbardella, P Razzore, S Campione, ... Reviews in Endocrine and Metabolic Disorders 22 (3), 511-525, 2021 | 27 | 2021 |
| Expected and paradoxical effects of obesity on cancer treatment response M Gallo, V Adinolfi, V Barucca, N Prinzi, V Renzelli, L Barrea, ... Reviews in Endocrine and Metabolic Disorders, 1-22, 2020 | 26 | 2020 |
| Intrapancreatic accessory spleen false positive to 68Ga-Dotatoc: case report and literature review F Lancellotti, L Sacco, S Cerasari, V Bellato, S Cicconi, A Ciardi, ... World Journal of Surgical Oncology 17, 1-7, 2019 | 22 | 2019 |
| Neuroendocrine carcinomas with atypical proliferation index and clinical behavior: a systematic review T Feola, R Centello, F Sesti, G Puliani, M Verrico, V Di Vito, C Di Gioia, ... Cancers 13 (6), 1247, 2021 | 20 | 2021 |
| Selenium supplementation in pregnant women with autoimmune thyroiditis: a practical approach M Minnetti, V Sada, T Feola, E Giannetta, C Pozza, D Gianfrilli, AM Isidori, ... Nutrients 14 (11), 2234, 2022 | 19 | 2022 |
| Immune checkpoint inhibitors: new weapons against medullary thyroid cancer? S Di Molfetta, A Dotto, G Fanciulli, T Florio, T Feola, A Colao, A Faggiano Frontiers in Endocrinology 12, 667784, 2021 | 19 | 2021 |
| Laryngeal neuroendocrine tumor with elevated serum calcitonin: a diagnostic and therapeutic challenge. Case report and review of literature T Feola, G Puliani, F Sesti, R Modica, M Biffoni, C Di Gioia, R Carletti, ... Frontiers in Endocrinology 11, 397, 2020 | 18 | 2020 |
| Prognostic significance of laterality in lung neuroendocrine tumors A La Salvia, I Persano, A Siciliani, M Verrico, M Bassi, R Modica, ... Endocrine 76 (3), 733-746, 2022 | 16 | 2022 |
| Sleep disorders in patients with craniopharyngioma: a physiopathological and practical update A Romigi, T Feola, S Cappellano, M De Angelis, G Pio, M Caccamo, ... Frontiers in Neurology 12, 817257, 2022 | 16 | 2022 |
